OpenAI seen preparing for 2027 IPO at $1 trln valuation- Reuters
Investing.com -- GE HealthCare reported third-quarter earnings broadly in line with expectations and raised the lower end of its full-year profit outlook.
Shares in the medical device maker slid 2% in premarket trading on Wednesday.
Adjusted earnings per share (EPS) came in at $1.07, broadly matching the consensus estimate of $1.05. Revenue rose 6% year on year to $5.14 billion, slightly above the $5.08 billion forecast.
Organic revenue grew 4%, supported by strong demand in Europe, the Middle East and Africa (EMEA) and the United States, the company said.
Adjusted EBIT stood at $761 million, down from $795 million a year earlier.
“We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment," said GE HealthCare President and CEO Peter Arduini.
The company lifted the lower end of its full-year 2025 adjusted EPS guidance to a range of $4.51 to $4.63, compared with its previous range of $4.43 to $4.63, and above the $4.52 consensus estimate.
GE HealthCare reaffirmed all other financial targets.